OpenURL Connection Search

Select item for more details and to access through your institution.

Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer.
Published in:
2020
By:
- Miyo, Masaaki;
- Kato, Takeshi;
- Yoshino, Takayuki;
- Yamanaka, Takeharu;
- Bando, Hideaki;
- Satake, Hironaga;
- Yamazaki, Kentaro;
- Taniguchi, Hiroya;
- Oki, Eiji;
- Kotaka, Masahito;
- Oba, Koji;
- Miyata, Yoshinori;
- Muro, Kei;
- Komatsu, Yoshito;
- Baba, Hideo;
- Tsuji, Akihito
Publication type:
journal article
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study.
Published in:
Investigational New Drugs, 2021, v. 39, n. 6, p. 1649, doi. 10.1007/s10637-021-01125-2
By:
- Kotani, Daisuke;
- Yoshino, Takayuki;
- Kotaka, Masahito;
- Kawazoe, Akihito;
- Masuishi, Toshiki;
- Taniguchi, Hiroya;
- Yamazaki, Kentaro;
- Yamanaka, Takeharu;
- Oki, Eiji;
- Muro, Kei;
- Komatsu, Yoshito;
- Bando, Hideaki;
- Satake, Hironaga;
- Kato, Takeshi;
- Tsuji, Akihito
Publication type:
Article
Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.
Published in:
International Journal of Clinical Oncology, 2021, v. 26, n. 7, p. 1238, doi. 10.1007/s10147-021-01902-2
By:
- Kato, Takeshi;
- Kagawa, Yoshinori;
- Kuboki, Yasutoshi;
- Gamoh, Makio;
- Komatsu, Yoshito;
- Yasui, Hirofumi;
- Satake, Hironaga;
- Oki, Eiji;
- Tanioka, Hiroaki;
- Kotaka, Masahito;
- Makiyama, Akitaka;
- Denda, Tadamichi;
- Goto, Masahiro;
- Yoshino, Takayuki;
- Yamazaki, Kentaro;
- Soeda, Junpei;
- Shibuya, Kazunori;
- Iwata, Masaru;
- Oba, Koji;
- Yamaguchi, Kensei
Publication type:
Article
Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).
Published in:
International Journal of Clinical Oncology, 2020, v. 25, n. 8, p. 1515, doi. 10.1007/s10147-020-01701-1
By:
- Kotaka, Masahito;
- Iwamoto, Shigeyoshi;
- Satake, Hironaga;
- Sakai, Daisuke;
- Kudo, Toshihiro;
- Fukunaga, Mutsumi;
- Konishi, Ken;
- Ide, Yoshihito;
- Ikumoto, Taro;
- Tsuji, Akihito;
- Sano, Yasushi;
- Kato, Takeshi;
- Sugimoto, Naotoshi;
- Satoh, Taroh;
- Kanazawa, Akiyoshi;
- Kurata, Takayasu;
- Yamanaka, Takeharu;
- Tomita, Naohiro
Publication type:
Article
Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
Published in:
International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1291, doi. 10.1007/s10147-020-01656-3
By:
- Ohta, Takashi;
- Kato, Takeshi;
- Kawakami, Hisato;
- Miyake, Yasuhiro;
- Goto, Masahiro;
- Iwamoto, Shigeyoshi;
- Otsuji, Toshio;
- Nakamura, Masato;
- Sugimoto, Naotoshi;
- Okamura, Shu;
- Kotaka, Masahito;
- Tsujie, Masaki;
- Tokunaga, Yukihiko;
- Mishima, Hideyuki;
- Hata, Taishi;
- Shimokawa, Toshio;
- Kurokawa, Yukinori;
- Satoh, Taroh
Publication type:
Article
Bladder-Sparing Extended Resection of Locally Advanced Rectal Cancer Involving the Prostate and Seminal Vesicles.
Published in:
Surgery Today, 2007, v. 37, n. 10, p. 845, doi. 10.1007/s00595-007-3492-x
By:
- Norio Saito;
- Takanori Suzuki;
- Masanori Sugito;
- Masaaki Ito;
- Akihiro Kobayashi;
- Toshiyuki Tanaka;
- Masahito Kotaka;
- Hirokazu Karaki;
- Takaya Kobatake;
- Yoshiyuki Tsunoda;
- Akio Shiomi;
- Masaaki Yano;
- Nozomi Minagawa;
- Yuji Nishizawa
Publication type:
Article
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).
Published in:
Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
By:
- Arai, Hiroyuki;
- Tsuda, Takashi;
- Sunakawa, Yu;
- Shimokawa, Mototsugu;
- Akiyoshi, Kohei;
- Tokunaga, Shinya;
- Shoji, Hirokazu;
- Kunieda, Kenji;
- Kotaka, Masahito;
- Matsumoto, Toshihiko;
- Nagata, Yusuke;
- Mizukami, Takuro;
- Mizuki, Fumitaka;
- Danenberg, Kathleen D.;
- Boku, Narikazu;
- Nakajima, Takako Eguchi
Publication type:
Article
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7808, doi. 10.1002/cam4.5541
By:
- Kanai, Masashi;
- Kawaguchi, Takahisa;
- Kotaka, Masahito;
- Manaka, Dai;
- Hasegawa, Junichi;
- Takagane, Akinori;
- Munemoto, Yoshinori;
- Kato, Takeshi;
- Eto, Tetsuya;
- Touyama, Tetsuo;
- Matsui, Takanori;
- Shinozaki, Katsunori;
- Matsumoto, Shigemi;
- Mizushima, Tsunekazu;
- Mori, Masaki;
- Sakamoto, Junichi;
- Ohtsu, Atsushi;
- Yoshino, Takayuki;
- Saji, Shigetoyo;
- Matsuda, Fumihiko
Publication type:
Article
Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial
Published in:
Cancer Medicine, 2020, v. 9, n. 24, p. 9419, doi. 10.1002/cam4.3564
By:
- Ooki, Akira;
- Morita, Satoshi;
- Tsuji, Akihito;
- Iwamoto, Shigeyoshi;
- Hara, Hiroki;
- Tanioka, Hiroaki;
- Satake, Hironaga;
- Kataoka, Masato;
- Kotaka, Masahito;
- Kagawa, Yoshinori;
- Nakamura, Masato;
- Shingai, Tatsushi;
- Ishikawa, Masashi;
- Miyake, Yasuhiro;
- Suto, Takeshi;
- Hashiguchi, Yojiro;
- Yabuno, Taichi;
- Ando, Masahiko;
- Sakamoto, Junichi;
- Yamaguchi, Kensei
Publication type:
Article
Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial.
Published in:
Cancer Medicine, 2020, v. 9, n. 5, p. 1779, doi. 10.1002/cam4.2826
By:
- Ooki, Akira;
- Morita, Satoshi;
- Iwamoto, Shigeyoshi;
- Hara, Hiroki;
- Tanioka, Hiroaki;
- Satake, Hironaga;
- Kataoka, Masato;
- Kotaka, Masahito;
- Kagawa, Yoshinori;
- Nakamura, Masato;
- Shingai, Tatsushi;
- Ishikawa, Masashi;
- Miyake, Yasuhiro;
- Suto, Takeshi;
- Hashiguchi, Yojiro;
- Yabuno, Taichi;
- Sakamoto, Junichi;
- Tsuji, Akihito;
- Ando, Masahiko;
- Yamaguchi, Kensei
Publication type:
Article
A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial.
Published in:
Cancer Medicine, 2018, v. 7, n. 9, p. 4217, doi. 10.1002/cam4.1623
By:
- Iwamoto, Shigeyoshi;
- Ooki, Akira;
- Morita, Satoshi;
- Hara, Hiroki;
- Tanioka, Hiroaki;
- Satake, Hironaga;
- Kataoka, Masato;
- Kotaka, Masahito;
- Kagawa, Yoshinori;
- Nakamura, Masato;
- Shingai, Tatsushi;
- Ishikawa, Masashi;
- Miyake, Yasuhiro;
- Sudo, Takeshi;
- Hashiguchi, Yojiro;
- Yabuno, Taichi;
- Sakamoto, Junichi;
- Tsuji, Akihito;
- Ando, Masahiko;
- Yamaguchi, Kensei
Publication type:
Article
A multicenter, prospective, phase II trial of second‐line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti‐EGFR antibody: HGCSG1801.
Published in:
International Journal of Cancer, 2024, v. 155, n. 12, p. 2223, doi. 10.1002/ijc.35116
By:
- Nakatsumi, Hiroshi;
- Komatsu, Yoshito;
- Harada, Kazuaki;
- Kawamoto, Yasuyuki;
- Yuki, Satoshi;
- Sawada, Kentaro;
- Ishiguro, Atsushi;
- Sogabe, Susumu;
- Ando, Takayuki;
- Sasaki, Yusuke;
- Yoshikawa, Ayumu;
- Nakamura, Michio;
- Dazai, Masayoshi;
- Tateyama, Miki;
- Muto, Osamu;
- Kotaka, Masahito;
- Sagawa, Tamotsu;
- Muranaka, Tetsuhito;
- Hatanaka, Kazuteru;
- Takagi, Ryo
Publication type:
Article
Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan.
Published in:
PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234314
By:
- Ogata, Misato;
- Kotaka, Masahito;
- Ogata, Takatsugu;
- Hatachi, Yukimasa;
- Yasui, Hisateru;
- Kato, Takeshi;
- Tsuji, Akihito;
- Satake, Hironaga
Publication type:
Article
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan.
Published in:
2021
By:
- Ikoma, Tatsuki;
- Shimokawa, Mototsugu;
- Kotaka, Masahito;
- Matsumoto, Toshihiko;
- Nagai, Hiroki;
- Boku, Shogen;
- Shibata, Nobuhiro;
- Yasui, Hisateru;
- Satake, Hironaga
Publication type:
journal article
First-line chemotherapy with capecitabine/oxaliplatin for advanced gastric cancer: A phase I study.
Published in:
Molecular & Clinical Oncology, 2017, v. 7, n. 3, p. 347, doi. 10.3892/mco.2017.1335
By:
- HIRONAGA SATAKE;
- HISATERU YASUI;
- TAKESHI KOTAKE;
- YOSHIHIRO OKITA;
- YUKIMASA HATACHI;
- MASAHITO KOTAKA;
- TAKESHI KATO;
- AKIHITO TSUJI
Publication type:
Article
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure-Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial).
Published in:
2020
By:
- Takeshi Suzuki;
- Yasutaka Sukawa;
- Imamura, Chiyo K.;
- Toshiki Masuishi;
- Hironaga Satake;
- Yosuke Kumekawa;
- Shinsuke Funakoshi;
- Masahito Kotaka;
- Yoshiki Horie;
- Sadayuki Kawai;
- Hiroyuki Okuda;
- Tetsuji Terazawa;
- Chihiro Kondoh;
- Ken Kato;
- Kenichi Yoshimura;
- Hideki Ishikawa;
- Yasuo Hamamoto;
- Narikazu Boku;
- Hiromasa Takaishi;
- Takanori Kanai
Publication type:
journal article
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.
Published in:
2018
By:
- Eiji Oki;
- Takeshi Kato;
- Hideaki Bando;
- Takayuki Yoshino;
- Kei Muro;
- Hiroya Taniguchi;
- Yoshinori Kagawa;
- Kentaro Yamazaki;
- Tatsuro Yamaguchi;
- Akihito Tsuji;
- Shigeyoshi Iwamoto;
- Goro Nakayama;
- Yasunori Emi;
- Tetsuo Touyama;
- Masato Nakamura;
- Masahito Kotaka;
- Hideki Sakisaka;
- Takeharu Yamanaka;
- Akiyoshi Kanazawa;
- Oki, Eiji
Publication type:
journal article
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.
Published in:
2017
By:
- Sunakawa, Yu;
- Ichikawa, Wataru;
- Tsuji, Akihito;
- Denda, Tadamichi;
- Segawa, Yoshihiko;
- Negoro, Yuji;
- Shimada, Ken;
- Kochi, Mitsugu;
- Nakamura, Masato;
- Kotaka, Masahito;
- Tanioka, Hiroaki;
- Takagane, Akinori;
- Tani, Satoshi;
- Yamaguchi, Tatsuro;
- Watanabe, Takanori;
- Takeuchi, Masahiro;
- Fujii, Masashi;
- Nakajima, Toshifusa
Publication type:
journal article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
Published in:
2021
By:
- Ishibashi, Keiichiro;
- Aoyama, Toru;
- Kotaka, Masahito;
- Satake, Hironaga;
- Tsuji, Yasushi;
- Kataoka, Masato;
- Nakamura, Masato;
- Nagata, Naoki;
- Sakamoto, Junichi;
- Oba, Koji;
- Mishima, Hideyuki
Publication type:
journal article
Correction to: A placebo‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy.
Published in:
2021
By:
- Kotaka, Masahito;
- Saito, Yoji;
- Kato, Takeshi;
- Satake, Hironaga;
- Makiyama, Akitaka;
- Tsuji, Yasushi;
- Shinozaki, Katsunori;
- Fujiwara, Toshiyoshi;
- Mizushima, Tsunekazu;
- Harihara, Yasushi;
- Nagata, Naoki;
- Kurihara, Naoto;
- Ando, Masahiko;
- Kusakawa, Genichi;
- Sakai, Takumi;
- Uchida, Yugo;
- Takamoto, Mikihiro;
- Kimoto, Saki;
- Hyodo, Ichinosuke
Publication type:
Correction Notice
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
Published in:
Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 5, p. 607, doi. 10.1007/s00280-020-04135-8
By:
- Kotaka, Masahito;
- Saito, Yoji;
- Kato, Takeshi;
- Satake, Hironaga;
- Makiyama, Akitaka;
- Tsuji, Yasushi;
- Shinozaki, Katsunori;
- Fujiwara, Toshiyoshi;
- Mizushima, Tsunekazu;
- Harihara, Yasushi;
- Nagata, Naoki;
- Kurihara, Naoto;
- Ando, Masahiko;
- Kusakawa, Genichi;
- Sakai, Takumi;
- Uchida, Yugo;
- Takamoto, Mikihiro;
- Kimoto, Saki;
- Hyodo, Ichinosuke
Publication type:
Article
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).
Published in:
Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 2, p. 285, doi. 10.1007/s00280-020-04108-x
By:
- Samura, Hironori;
- Oki, Eiji;
- Okumura, Hiroshi;
- Yoshida, Takefumi;
- Kai, Seiichiro;
- Kobayashi, Kazuma;
- Kinjo, Tatsuya;
- Mori, Shinichiro;
- Tohyama, Tetsuo;
- Ohgaki, Kippei;
- Kawanaka, Hirofumi;
- Makiyama, Akitaka;
- Ureshino, Norio;
- Kotaka, Masahito;
- Shimose, Takayuki;
- Ando, Koji;
- Saeki, Hiroshi;
- Baba, Hideo;
- Maehara, Yoshihiko;
- Mori, Masaki
Publication type:
Article
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer.
Published in:
2019
By:
- Yoshino, Takayuki;
- Kotaka, Masahito;
- Shinozaki, Katsunori;
- Touyama, Tetsuo;
- Manaka, Dai;
- Matsui, Takanori;
- Ishigure, Kiyoshi;
- Hasegawa, Junichi;
- Inoue, Keiji;
- Munemoto, Yoshinori;
- Takagane, Akinori;
- Ishikawa, Hiroshi;
- Ishida, Hideyuki;
- Ogata, Yutaka;
- Oba, Koji;
- Goto, Koichi;
- Sakamoto, Junichi;
- Maehara, Yoshihiko;
- Ohtsu, Atsushi
Publication type:
journal article
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
Published in:
2018
By:
- Satake, Hironaga;
- Sagawa, Tamotsu;
- Fujikawa, Koshi;
- Hatachi, Yukimasa;
- Yasui, Hisateru;
- Kotaka, Masahito;
- Kato, Takeshi;
- Tsuji, Akihito
Publication type:
journal article
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
Published in:
Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 75, doi. 10.1007/s00280-015-2757-0
By:
- Kotaka, Masahito;
- Yoshino, Takayuki;
- Oba, Koji;
- Shinozaki, Katsunori;
- Touyama, Tetsuo;
- Manaka, Dai;
- Matsui, Takanori;
- Ishigure, Kiyoshi;
- Hasegawa, Junichi;
- Inoue, Keiji;
- Goto, Koichi;
- Sakamoto, Junichi;
- Saji, Shigetoyo;
- Ohtsu, Atsushi;
- Watanabe, Toshiaki
Publication type:
Article
A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
Published in:
Drug Design, Development & Therapy, 2015, v. 9, n. 2015, p. 6067, doi. 10.2147/DDDT.S94901
By:
- Yoichiro Yoshida;
- Keiji Hirata;
- Hiroshi Matsuoka;
- Shigeyoshi Iwamoto;
- Masahito Kotaka;
- Hideto Fujita;
- Naoya Aisu;
- Seiichiro Hoshino;
- Takeo Kosaka;
- Kotaro Maeda;
- Fumiaki Kiyomi;
- Yuichi Yamashita
Publication type:
Article
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Published in:
British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
By:
- Kuboki, Yasutoshi;
- Terazawa, Tetsuji;
- Masuishi, Toshiki;
- Nakamura, Masato;
- Watanabe, Jun;
- Ojima, Hitoshi;
- Makiyama, Akitaka;
- Kotaka, Masahito;
- Hara, Hiroki;
- Kagawa, Yoshinori;
- Sugimoto, Naotoshi;
- Kawakami, Hisato;
- Takashima, Atsuo;
- Kajiwara, Takeshi;
- Oki, Eiji;
- Sunakawa, Yu;
- Ishihara, Soichiro;
- Taniguchi, Hiroya;
- Nakajima, Takako Eguchi;
- Morita, Satoshi
Publication type:
Article
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial).
Published in:
2021
By:
- Ueno, Hideki;
- Ishiguro, Megumi;
- Nakatani, Eiji;
- Ishikawa, Toshiaki;
- Uetake, Hiroyuki;
- Murotani, Kenta;
- Matsui, Shigeyuki;
- Teramukai, Satoshi;
- Sugai, Tamotsu;
- Ajioka, Yoichi;
- Maruo, Hirotoshi;
- Kotaka, Masahito;
- Tsujie, Masaki;
- Munemoto, Yoshinori;
- Yamaguchi, Takashi;
- Kuroda, Hisashi;
- Fukunaga, Mutsumi;
- Tomita, Naohiro;
- Sugihara, Kenichi
Publication type:
journal article
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Published in:
2020
By:
- Masuishi, Toshiki;
- Tsuji, Akihito;
- Kotaka, Masahito;
- Nakamura, Masato;
- Kochi, Mitsugu;
- Takagane, Akinori;
- Shimada, Ken;
- Denda, Tadamichi;
- Segawa, Yoshihiko;
- Tanioka, Hiroaki;
- Hara, Hiroki;
- Sagawa, Tamotsu;
- Watanabe, Takanori;
- Takahashi, Takao;
- Negoro, Yuji;
- Manaka, Dai;
- Fujita, Hideto;
- Suto, Takeshi;
- Takeuchi, Masahiro;
- Ichikawa, Wataru
Publication type:
journal article
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G.
Published in:
Targeted Oncology, 2024, v. 19, n. 2, p. 181, doi. 10.1007/s11523-024-01043-2
By:
- Matsumoto, Toshihiko;
- Yamamoto, Yoshiyuki;
- Kotaka, Masahito;
- Masuishi, Toshiki;
- Tsuji, Yasushi;
- Shoji, Hirokazu;
- Hirata, Kenro;
- Tsuduki, Takao;
- Makiyama, Akitaka;
- Izawa, Naoki;
- Takahashi, Naoki;
- Tsuda, Masahiro;
- Yasui, Hisateru;
- Ohta, Takashi;
- Kito, Yosuke;
- Otsu, Satoshi;
- Hironaka, Shuichi;
- Yamazaki, Kentaro;
- Boku, Narikazu;
- Hyodo, Ichinosuke
Publication type:
Article
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
Published in:
Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
By:
- Sunakawa, Yu;
- Kuboki, Yasutoshi;
- Watanabe, Jun;
- Terazawa, Tetsuji;
- Kawakami, Hisato;
- Yokota, Mitsuru;
- Nakamura, Masato;
- Kotaka, Masahito;
- Sugimoto, Naotoshi;
- Ojima, Hitoshi;
- Oki, Eiji;
- Kajiwara, Takeshi;
- Yamamoto, Yoshiyuki;
- Tsuji, Yasushi;
- Denda, Tadamichi;
- Tamura, Takao;
- Ishihara, Soichiro;
- Taniguchi, Hiroya;
- Nakajima, Takako Eguchi;
- Morita, Satoshi
Publication type:
Article
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.
Published in:
2017
By:
- Sunakawa, Yu;
- Tsuji, Akihito;
- Denda, Tadamichi;
- Segawa, Yoshihiko;
- Negoro, Yuji;
- Shimada, Ken;
- Kochi, Mitsugu;
- Nakamura, Masato;
- Kotaka, Masahito;
- Tanioka, Hiroaki;
- Takagane, Akinori;
- Tani, Satoshi;
- Yamaguchi, Tatsuro;
- Watanabe, Takanori;
- Takeuchi, Masahiro;
- Fujii, Masashi;
- Ichikawa, Wataru
Publication type:
journal article
Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05).
Published in:
2016
By:
- Tsuji, Akihito;
- Sunakawa, Yu;
- Ichikawa, Wataru;
- Nakamura, Masato;
- Kochi, Mitsugu;
- Denda, Tadamichi;
- Yamaguchi, Tatsuro;
- Shimada, Ken;
- Takagane, Akinori;
- Tani, Satoshi;
- Kotaka, Masahito;
- Kuramochi, Hidekazu;
- Furushima, Kaoru;
- Koike, Junichi;
- Yonemura, Yutaka;
- Takeuchi, Masahiro;
- Fujii, Masashi;
- Nakajima, Toshifusa
Publication type:
journal article
Impact of early tumor shrinkage on quality of life in patients treated with first-line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: results of Phase II QUACK trial.
Published in:
2022
By:
- Ooki, Akira;
- Morita, Satoshi;
- Tsuji, Akihito;
- Iwamoto, Shigeyoshi;
- Hara, Hiroki;
- Tanioka, Hiroaki;
- Satake, Hironaga;
- Kataoka, Masato;
- Kotaka, Masahito;
- Kagawa, Yoshinori;
- Nakamura, Masato;
- Shingai, Tatsushi;
- Ishikawa, Masashi;
- Miyake, Yasuhiro;
- Suto, Takeshi;
- Hashiguchi, Yojiro;
- Yabuno, Taichi;
- Ando, Masahiko;
- Sakamoto, Junichi;
- Yamaguchi, Kensei
Publication type:
journal article
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
Published in:
Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
By:
- Tanioka, Hiroaki;
- Miyamoto, Yuji;
- Tsuji, Akihito;
- Asayama, Masako;
- Shiraishi, Takeshi;
- Yuki, Satoshi;
- Kotaka, Masahito;
- Makiyama, Akitaka;
- Shimokawa, Mototsugu;
- Shimose, Takayuki;
- Masuda, Satohiro;
- Yamaguchi, Takuhiro;
- Komatsu, Yoshito;
- Saeki, Hiroshi;
- Emi, Yasunori;
- Baba, Hideo;
- Oki, Eiji;
- Maehara, Yoshihiko
Publication type:
Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
Published in:
Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
By:
- Terazawa, Tetsuji;
- Kato, Takeshi;
- Goto, Masahiro;
- Ohta, Katsuya;
- Satake, Hironaga;
- Noura, Shingo;
- Kagawa, Yoshinori;
- Kawakami, Hisato;
- Hasegawa, Hiroko;
- Yanagihara, Kazuhiro;
- Shingai, Tatsushi;
- Nakata, Ken;
- Kotaka, Masahito;
- Hiraki, Masayuki;
- Konishi, Ken;
- Nakae, Shiro;
- Sakai, Daisuke;
- Kurokawa, Yukinori;
- Shimokawa, Toshio;
- Tsujinaka, Toshimasa
Publication type:
Article
Hepatectomy Followed by Adjuvant Chemotherapy with 3‐Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Published in:
Oncologist, 2021, v. 26, n. 7, p. e1125, doi. 10.1002/onco.13816
By:
- Satake, Hironaga;
- Hashida, Hiroki;
- Tanioka, Hiroaki;
- Miyake, Yasuhiro;
- Yoshioka, Shinichi;
- Watanabe, Takanori;
- Matsuura, Masato;
- Kyogoku, Takahisa;
- Inukai, Michio;
- Kotake, Takeshi;
- Okita, Yoshihiro;
- Matsumoto, Toshihiko;
- Yasui, Hisateru;
- Kotaka, Masahito;
- Kato, Takeshi;
- Kaihara, Satoshi;
- Tsuji, Akihito
Publication type:
Article
Phase II Study of Panitumumab Monotherapy in Chemotherapy‐Naïve Frail or Elderly Patients with Unresectable RAS Wild‐Type Colorectal Cancer: OGSG 1602.
Published in:
Oncologist, 2021, v. 26, n. 1, p. 17, doi. 10.1002/ONCO.13523
By:
- Terazawa, Tetsuji;
- Kato, Takeshi;
- Goto, Masahiro;
- Ohta, Katsuya;
- Noura, Shingo;
- Satake, Hironaga;
- Kagawa, Yoshinori;
- Kawakami, Hisato;
- Hasegawa, Hiroko;
- Yanagihara, Kazuhiro;
- Shingai, Tatsushi;
- Nakata, Ken;
- Kotaka, Masahito;
- Hiraki, Masayuki;
- Konishi, Ken;
- Nakae, Shiro;
- Sakai, Daisuke;
- Kurokawa, Yukinori;
- Shimokawa, Toshio;
- Satoh, Taroh
Publication type:
Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Published in:
Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
By:
- Satake, Hironaga;
- Kato, Takeshi;
- Oba, Koji;
- Kotaka, Masahito;
- Kagawa, Yoshinori;
- Yasui, Hisateru;
- Nakamura, Masato;
- Watanabe, Takanori;
- Matsumoto, Toshihiko;
- Kii, Takayuki;
- Terazawa, Tetsuji;
- Makiyama, Akitaka;
- Takano, Nao;
- Yokota, Mitsuru;
- Okita, Yoshihiro;
- Matoba, Koreatsu;
- Hasegawa, Hiroko;
- Tsuji, Akihito;
- Komatsu, Yoshito;
- Yoshino, Takayuki
Publication type:
Article
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.
Published in:
2015
By:
- Soda, Hitoshi;
- Maeda, Hiromichi;
- Hasegawa, Junichi;
- Takahashi, Takao;
- Hazama, Shoichi;
- Fukunaga, Mutsumi;
- Kono, Emiko;
- Kotaka, Masahito;
- Sakamoto, Junichi;
- Nagata, Naoki;
- Oba, Koji;
- Mishima, Hideyuki
Publication type:
journal article
DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy.
Published in:
Cancer Science, 2022, v. 113, n. 4, p. 1531, doi. 10.1111/cas.15226
By:
- Miyo, Masaaki;
- Kato, Takeshi;
- Nakamura, Yoshiaki;
- Taniguchi, Hiroya;
- Takahashi, Yusuke;
- Ishii, Masayuki;
- Okita, Kenji;
- Ando, Koji;
- Yukami, Hiroki;
- Mishima, Saori;
- Yamazaki, Kentaro;
- Kotaka, Masahito;
- Watanabe, Jun;
- Oba, Koji;
- Aleshin, Alexey;
- Billings, Paul R.;
- Rabinowitz, Matthew;
- Kotani, Daisuke;
- Oki, Eiji;
- Takemasa, Ichiro
Publication type:
Article
Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer.
Published in:
Cancer Science, 2021, v. 112, n. 11, p. 4669, doi. 10.1111/cas.15092
By:
- Satoru Iwasa;
- Kei Muro;
- Satoshi Morita;
- Young Suk Park;
- Masato Nakamura;
- Masahito Kotaka;
- Tomohiro Nishina;
- Hiroshi Matsuoka;
- Joong Bae Ahn;
- Keun-Wook Lee;
- Yong Sang Hong;
- Sae Won Han;
- Sang-Hee Cho;
- Dong-Sheng Zhang;
- Wei-Jia Fang;
- Li Bai;
- Xiang-Lin Yuan;
- Ying Yuan;
- Yasuhide Yamada;
- Junichi Sakamoto
Publication type:
Article
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first‐line treatment.
Published in:
Cancer Science, 2021, v. 112, n. 6, p. 2436, doi. 10.1111/cas.14904
By:
- Fujimoto, Yoshiaki;
- Oki, Eiji;
- Qiu, Shichao;
- Nakanishi, Ryota;
- Makiyama, Akitaka;
- Miyamoto, Yuji;
- Kotaka, Masahito;
- Shimokawa, Mototsugu;
- Ando, Koji;
- Kimura, Yasue;
- Kitao, Hiroyuki;
- Maehara, Yoshihiko;
- Mori, Masaki
Publication type:
Article

Found: 43